Takeda Pharmaceutical Company Limited (TYO:4502)

Revenue Breakdown 2

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
GI Revenue (Post-FY2024 Reporting)	1.41T	1.36T
GI Revenue (Post-FY2024 Reporting) Growth	3.71%	11.58%
Rare Diseases Revenue (Post-FY2024 Reporting)	762.70B	752.90B
Rare Diseases Revenue (Post-FY2024 Reporting) Growth	1.30%	9.37%
PDT Revenue (Post-FY2024 Reporting)	1.06T	1.03T
PDT Revenue (Post-FY2024 Reporting) Growth	2.42%	14.26%
Oncology Revenue (Post-FY2024 Reporting)	580.20B	560.43B
Oncology Revenue (Post-FY2024 Reporting) Growth	3.53%	21.21%
Vaccines Revenue	59.60B	55.41B
Vaccines Revenue Growth	7.56%	10.04%
Neuroscience Revenue (Post-FY2024 Reporting)	414.30B	565.82B
Neuroscience Revenue (Post-FY2024 Reporting) Growth	-26.78%	-9.76%
Other Product Revenue (Post-FY2024 Reporting)	224.00B	257.30B
Other Product Revenue (Post-FY2024 Reporting) Growth	-12.94%	-18.50%
Revenue (Total)	4.51T	4.58T
Revenue (Total) Growth	-1.65%	7.45%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
Japan Revenue	433.20B	418.46B
Japan Revenue Growth	3.52%	-7.29%
United States Revenue	2.16T	2.38T
United States Revenue Growth	-9.03%	8.38%
Europe and Canada Revenue	1.15T	1.06T
Europe and Canada Revenue Growth	8.62%	9.14%
Latin America Revenue	254.20B	235.85B
Latin America Revenue Growth	7.78%	19.05%
China Revenue	195.00B	191.74B
China Revenue Growth	1.70%	9.66%
Asia (ex-Japan & China) Revenue	98.60B	99.39B
Asia (ex-Japan & China) Revenue Growth	-0.80%	15.07%
Asia (ex-Japan) Revenue	293.60B	291.13B
Asia (ex-Japan) Revenue Growth	0.85%	11.45%
Russia / CIS Revenue	79.70B	72.36B
Russia / CIS Revenue Growth	10.15%	-0.33%
Other Geographic Revenue	133.90B	128.85B
Other Geographic Revenue Growth	3.92%	9.28%
Revenue (Other)	120.00M	3.00M
Revenue (Total)	4.51T	4.58T
Revenue (Total) Growth	-1.65%	7.45%

Updated Mar 31, 2026. Data Source: Fiscal.ai.